From €3250EUR$3,450USD£2,779GBP
- Report
- October 2023
- 145 Pages
Global
From €2967EUR$3,150USD£2,537GBP
- Report
- August 2023
- 145 Pages
Global
From €2967EUR$3,150USD£2,537GBP
- Report
- July 2023
- 145 Pages
Global
From €2967EUR$3,150USD£2,537GBP
- Report
- January 2023
- 154 Pages
Global
From €4192EUR$4,450USD£3,584GBP
- Report
- July 2023
- 148 Pages
Europe
From €3250EUR$3,450USD£2,779GBP
- Report
- June 2023
- 146 Pages
Asia Pacific
From €3250EUR$3,450USD£2,779GBP
- Report
- January 2022
- 176 Pages
Global
From €4192EUR$4,450USD£3,584GBP
- Report
- September 2023
- 115 Pages
Global
From €4239EUR$4,500USD£3,625GBP
- Report
- May 2023
- 120 Pages
Global
From €4239EUR$4,500USD£3,625GBP
- Report
- April 2023
- 147 Pages
Global
From €4662EUR$4,949USD£3,986GBP
- Report
- April 2023
- 147 Pages
Global
From €4662EUR$4,949USD£3,986GBP
- Report
- December 2023
- 231 Pages
Global
€4705EUR$4,995USD£4,023GBP
- Report
- October 2023
- 146 Pages
Global
From €3909EUR$4,150USD£3,343GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €3231EUR$3,430USD£2,763GBP
€4616EUR$4,900USD£3,947GBP
- Report
- August 2023
- 300 Pages
Latin America
From €3231EUR$3,430USD£2,763GBP
€4616EUR$4,900USD£3,947GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €3231EUR$3,430USD£2,763GBP
€4616EUR$4,900USD£3,947GBP
- Report
- August 2023
- 300 Pages
Europe
From €3231EUR$3,430USD£2,763GBP
€4616EUR$4,900USD£3,947GBP
- Report
- August 2023
- 1300 Pages
Global
From €5868EUR$6,230USD£5,018GBP
€8384EUR$8,900USD£7,169GBP
- Report
- August 2023
- 51 Pages
South Korea
From €396EUR$420USD£338GBP
€565EUR$600USD£483GBP

The CRISPR market is a subset of the genomics market that focuses on the use of CRISPR-Cas9 technology for gene editing. CRISPR-Cas9 is a powerful tool that enables scientists to make precise changes to the genome of living organisms. This technology has been used to develop treatments for a variety of diseases, as well as to create new crops and livestock. CRISPR-Cas9 technology has also been used to create gene drives, which are designed to spread a desired trait through a population.
The CRISPR market is highly competitive, with a number of companies offering products and services related to gene editing. These companies include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, Caribou Biosciences, and ERS Genomics. These companies are developing a range of products, from gene editing tools to gene therapies, and are working to make CRISPR-Cas9 technology more accessible and affordable. Show Less Read more